Unpredictable disease fluctuations during the respiratory season make it difficult to differentiate between COVID-19, Flu, and RSV. And many cases go under reported.
For patients who feel sick, experienced symptoms may be nonspecific so it’s difficult to diagnose based on signs and symptoms alone. The challenge of differential diagnosis may lead to delays in clinical decision making, patient care and initiation of appropriate treatment and infection control measures. It is essential to accurately diagnose patients quickly to ensure they receive the best and most appropriate care.
That’s why Roche develops high-quality fully automated testing solutions, with our gold-standard PCR diagnostics systems, for the greatest confidence in assessing respiratory illnesses.
Get an early look at the solutions designed to help address your lab's needs now and well into the future.
*Turnaround times vary by assay.
For more information on these assays and more please contact us using the link below.
LEARN MORE ABOUT:
Gold-standard PCR diagnostics systems, for the greatest confidence in assessing respiratory illnesses.
ROCHE REPRESENTATIVE
Connect with a Roche representative on solutions for your lab and upcoming product launches.
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.
You are now leaving the website of Hoffmann-La Roche Ltd. ("Roche Canada"). Links to all external sites are provided as a resource to our visitors. Roche Canada assumes no responsibility for the content of these sites. Roche Canada has no control over these sites and the opinions, claims or comments contained in these sites should not be attributed to Roche Canada, unless otherwise specified.